TRPC6-targeted dexamethasone nanobubbles with ultrasound-guided theranostics for adriamycin-induced nephropathy
By simultaneously enhancing therapeutic efficacy, minimizing systemic toxicity, and enabling personalized imaging-guided treatment, Dex@NBs-TRPC6 introduces a transformative approach to GC-based renal therapy.
Authors
- Zhenqiang Fu (ORCID: https://orcid.org/0000-0003-3766-1083)
- Huijuan Mao (ORCID: https://orcid.org/0000-0001-7410-1486)
- Jiafa Ren (ORCID: https://orcid.org/0000-0002-7840-0536)
- Zhimin Huang (ORCID: https://orcid.org/0000-0001-9230-6039)
- Lin Wu (ORCID: https://orcid.org/0000-0001-6493-0125)
- Fang Yang (ORCID: https://orcid.org/0000-0002-8393-6853)
- Yang Liu (ORCID: https://orcid.org/0009-0003-1250-9904)
- Kang Liu (ORCID: https://orcid.org/0000-0002-2781-2581)
- Honglei Guo (ORCID: https://orcid.org/0000-0002-1610-8521)
Institutions
- Southeast University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Journal of Nanobiotechnology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1186/s12951-025-03487-8
- Citations
- 3
- Primary Topic
- Ultrasound and Hyperthermia Applications
- Type
- article
- Field-Weighted Citation Impact
- 2.02
Funders
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province
- Nanjing Medical University